Xtant Medical Holdings, Inc. XTNT

0.38 0.00 0.00% as of 25 Sep
Market cap
$52.9M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
19.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.81 0.50 1.58 1.09 0.87 0.64 0.33 0.26 0.12 0.08
P/FCF ratio
10.47 0.00 0.00 0.00 0.00 0.00 0.00 22.37 0.00 0.00
P/Operating CF
20.23 88.44 (157.49) (27.55) 113.13 37.34 (296.65) 9.49 15.97 (2.21)
P/B ratio
2.14 1.37 2.81 1.84 1.55 2.36 0.00 0.00 0.00 0.00
Price to Tangible BV
2.44 2.15 4.24 2.06 1.75 3.15 0.00 0.00 0.00 0.00
EV/Sales
0.87 0.74 1.75 1.00 0.81 0.94 1.43 2.16 2.56 1.50
EV/EBITDA
9.35 0.00 0.00 0.00 0.00 37.62 104.09 0.00 0.00 0.00
EV/Operating CF
9.32 (7.30) (16.82) (10.88) 102.46 (68.34) (224.31) 128.60 (389.79) (9.37)
EV/FCF
11.24 (5.55) (14.83) (8.42) (31.00) (24.55) (96.80) 184.45 (98.40) (6.68)
Quick Ratio
1.19 0.94 1.16 2.06 2.31 0.36 1.64 1.39 0.60 0.69
Current Ratio
2.65 2.35 2.82 3.24 4.00 1.22 3.43 2.88 1.54 1.57
Net Debt/EBITDA
0.65 (3.56) (2.29) 0.90 1.14 11.87 80.42 (1.34) (4.63) (421.63)
Debt/Assets
26.97% 36.45% 23.65% 25.87% 28.36% 43.65% 178.00% 169.25% 131.45% 90.56%
Debt/Equity
0.50 0.80 0.43 0.46 0.50 1.25 (1.74) (1.79) (2.37) (18.45)
Asset Turnover
1.42 1.26 1.19 1.01 1.15 1.26 1.44 0.95 0.66 0.63
Operating CF/Net income
2.52 0.72 (14.42) 0.63 (0.09) 0.10 0.05 (0.02) 0.01 0.74
Capex/Depreciation
(0.41) (0.88) (0.40) (1.21) (1.42) (0.63) (0.17) (0.06) (0.19) (0.80)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
10.59% (34.88%) 1.54% (26.09%) (21.36%) 47.31% 18.69% 136.82% 159.37% (2,162.11%)
ROA
5.29% (17.64%) 0.86% (14.77%) (10.09%) (16.60%) (18.36%) (92.16%) (41.96%) (13.67%)
ROIC
7.71% (10.64%) (9.43%) (14.44%) (8.60%) (1.55%) (5.14%) (134.10%) (30.55%) (3.90%)
Return on Tangible Assets
9.05% (33.80%) 1.31% (21.27%) (12.61%) (69.79%) (29.84%) (235.23%) (220.27%) (57.83%)
Average Days of Receivables
48.52 64.31 82.88 68.34 47.25 47.08 57.13 50.50 56.17 77.02
Research and Development Expense of Revenue
1.57% 2.03% 1.46% 1.58% 1.57% 1.23% 1.44% 2.36% 2.95% 3.79%
Selling, General and Administrative Expense of Revenue
55.92% 66.43% 70.41% 65.51% 64.19% 64.66% 67.77% 63.35% 67.60% 66.76%
Intangible Assets out of Total Assets
0.07 0.17 0.19 0.06 0.07 0.09 0.09 0.08 0.52 0.54
Share Based Compensation of Revenue
2.16% 3.51% 3.00% 4.25% 4.00% 2.03% 0.80% 0.96% 0.00% 0.00%
Graham Net Nets
0.32 0.28 0.16 0.37 0.43 0.13 (2.62) (2.94) (12.09) (14.40)
Graham Number
0.58 0.00 0.00 0.00 0.00 0.00 6.84 21.73 173.67 37.56
Earnings Yield
5.23% (27.27%) 0.00% (14.93%) (10.79%) (40.83%) (38.75%) (349.69%) (503.48%) (139.32%)
Free Cash Flow Yield
9.55% (26.57%) (7.49%) (10.95%) (3.03%) (5.95%) (4.54%) 4.47% (20.85%) (284.99%)
Revenue per Share
0.96 0.88 0.77 0.62 0.65 1.87 4.91 6.15 54.78 85.23
Operating CF per Share
0.09 (0.09) (0.08) (0.06) 0.01 (0.03) (0.03) 0.10 (0.36) (13.64)
Capex per Share
(0.02) (0.03) (0.01) (0.02) (0.02) (0.05) (0.04) (0.03) (1.07) (5.51)
Free Cash Flow per Share
0.07 (0.12) (0.09) (0.07) (0.02) (0.07) (0.07) 0.07 (1.43) (19.15)
Cash per Share
0.12 0.05 0.05 0.22 0.22 0.08 0.40 0.58 1.89 2.44
Shareholders Equity per Share
0.37 0.32 0.43 0.36 0.36 0.51 (3.36) (3.73) (38.93) (6.70)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.37 0.32 0.43 0.36 0.36 0.51 (3.36) (3.73) (38.93) (6.70)
Free Cash Flow
10.40 (15.63) (10.80) (6.90) (1.45) (2.03) (0.96) 0.85 (2.15) (20.22)
Working Capital
48.76 38.54 41.88 34.10 33.25 5.72 22.86 22.63 13.88 17.86
Capital Expenditures
(2.15) (3.73) (1.28) (1.56) (1.89) (1.30) (0.54) (0.37) (1.61) (5.82)
Net Current Asset Value
35.05 16.24 23.61 23.26 20.52 4.41 (55.11) (55.52) (124.70) (102.19)
EV/EBIT
16.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.03 0.01 0.03 0.03 0.02 0.01 0.01 0.02 0.06
Net Profit Margin
3.71% (14.03%) 0.72% (14.64%) (8.77%) (13.17%) (12.71%) (97.09%) (63.44%) (21.66%)
Price to Operating Income
14.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.84 0.42 0.37 0.22 0.26 0.48 0.67 0.92 0.85 0.46
Cash ROIC
6.77% (26.41%) (23.00%) (15.84%) (7.37%) (14.53%) (13.50%) (14.33%) (12.58%) (24.01%)
Accounts Receivable Turnover
6.96 5.67 5.78 6.44 7.88 6.27 6.43 6.36 5.21 5.24
Accounts Payable Turnover
8.44 6.55 6.80 8.46 8.19 7.38 5.12 3.60 3.16 2.53
Inventory Turnover
1.44 1.30 1.32 1.47 1.16 1.01 1.33 1.45 1.34 1.13
Average Days of Payables
28.26 58.92 71.85 49.31 41.91 56.78 36.03 82.17 106.39 146.37
Days of Inventory on Hand
222.46 287.48 375.68 244.23 287.62 412.45 265.13 219.90 251.74 345.99
Average Receivables
19.23 20.70 15.79 9.00 7.02 8.50 10.06 11.35 15.85 17.19
Average Payables
5.88 7.49 5.27 3.05 2.78 2.57 4.33 7.97 10.29 10.95
Average Inventory
34.45 37.76 27.09 17.62 19.68 18.75 16.70 19.86 24.34 24.48
Average Assets
93.99 93.22 76.42 57.46 48.08 42.31 44.79 76.06 124.90 142.56
Average Common Equity
46.96 47.16 42.76 32.53 22.70 (14.85) (43.99) (51.24) (32.89) 0.90

Fold the line items

Columns are period end dates